XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business and Geographical Reporting Segments (Tables)
3 Months Ended
Mar. 31, 2024
Business and Geographical Reporting Segments [Abstract]  
Segment Reporting Information by Segment
The following tables reflect results of operations from our business segments for the periods indicated below:

Three Months Ended March 31, 2024  
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
Total
 
Revenues, net
 
$
4,696
   
$
2,058
   
$
6,754
 
Cost of revenues
    2,195       1,479       3,674  
Gross profit
    2,501       579       3,080  
Gross profit %
    53.3 %     28.1 %     45.6 %
                         
Allocated expenses:
                       
Engineering and product development
   
196
     
45
     
241
 
Selling and marketing
   
2,753
     
265
     
3,018
 
Unallocated expenses
   
     
     
2,710
 
     
2,949
     
310
     
5,969
 
(Loss) income from operations
   
(448
)
   
269
     
(2,889
)
Interest expense
   
     
     
(524
)
Interest income
                45  
Net (loss) income
 
$
(448
)
 
$
269
   
$
(3,368
)

Three Months Ended March 31, 2023  
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
Total
 
Revenues, net
 
$
5,209
   
$
2,358
   
$
7,567
 
Cost of revenues
    2,020       1,159       3,179  
Gross profit
    3,189       1,199       4,388  
Gross profit %
    61.2 %     50.8 %     58.0 %
                         
Allocated expenses:
                       
Engineering and product development
   
245
     
70
     
315
 
Selling and marketing
   
3,353
     
389
     
3,742
 
Unallocated expenses
   
     
     
2,917
 
     
3,598
     
459
     
6,974
 
(Loss) income from operations
   
(409
)
   
740
     
(2,586
)
Interest expense
   
     
     
(286
)
Interest income
                37  
Net (loss) income
 
$
(409
)
 
$
740
   
$
(2,835
)
Depreciation and Amortization by Reportable Segment
For the three months ended March 31, 2024 and 2023, depreciation and amortization by reportable segment were as follows:

   
Three Months Ended March 31,
 
 
 
2024
   
2023
 
Dermatology recurring procedures
 
$
1,114
   
$
1,213
 
Dermatology procedures equipment
   
132
     
180
 
Unallocated expenses
   
3
     
4
 
Total
 
$
1,249
   
$
1,397
 
Disaggregation of Revenue by Geographical Region
The following tables present the Company’s revenue disaggregated by geographical region for the three months ended March 31, 2024 and 2023. Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from the Company’s distributors primarily in Asia.

Three Months Ended March 31, 2024  
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
Total
 
Domestic
 
$
4,320
   
$
141
   
$
4,461
 
Foreign
   
376
     
1,917
     
2,293
 
Total
 
$
4,696
   
$
2,058
   
$
6,754
 

Three Months Ended March 31, 2023
                 
Domestic
 
$
4,847
   
$
496
   
$
5,343
 
Foreign
   
362
     
1,862
     
2,224
 
Total
 
$
5,209
   
$
2,358
   
$
7,567